The drug manufacturer expects $4.3 billion to $4.5 billion in fiscal 2024 revenue. Analysts has been forecasting $4.2 billion.
Catalent issued a healthy outlook for fiscal 2024 revenue and announced a settlement with activist investor Elliott Investment Management that would include a review of the drug manufacturer’s business strategy.
Catalent earnings 9 cents a share for the fourth fiscal quarter ended in June. Analysts had been expecting 11 cents. Revenue of $1.07 billion exceeded the $1.05 billion analysts expected but dropped 17% from the year-earlier quarter.Catalent said it expects $4.3 billion to $4.5 billion in fiscal 2024 revenue, higher than analysts’ estimates of $4.2 billion.
Catalent also said it reached a settlement with activist investor Elliott. The deal includes adding four new independent directors to the board as well as the creation of a committee that would review the company’s strategy.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Catalent Reports Solid Outlook and Makes a Deal with ElliotThe drug manufacturer expects $4.3 billion to $4.5 billion in fiscal 2024 revenue. Analysts has been forecasting $4.2 billion.
Read more »
Stock Market Today: Dow, Nasdaq Close Higher; 3M Stock RisesLive coverage of stocks and financial news, including the S&P 500, Dow and Nasdaq Composite.
Read more »
Catalent stock jumps after cooperation agreement with activist investor Elliott InvestmentShares of Catalent Inc. jumped 4.1% in premarket trading Tuesday, after the maker of products used by drug makers and consumer health companies announced an...
Read more »
Tesla Inc. stock rises Monday, still underperforms marketShares of Tesla Inc. inched 0.10% higher to $238.82 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...
Read more »
Netflix Inc. stock rises Monday, still underperforms marketShares of Netflix Inc. inched 0.49% higher to $418.06 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...
Read more »
Microsoft Corp. stock rises Monday, still underperforms marketShares of Microsoft Corp. inched 0.22% higher to $323.70 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P...
Read more »